<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00876980</url>
  </required_header>
  <id_info>
    <org_study_id>HKCTR-676</org_study_id>
    <nct_id>NCT00876980</nct_id>
  </id_info>
  <brief_title>Obstructive Sleep Apnea and Diabetes Mellitus</brief_title>
  <official_title>The Effect of Nasal Continuous Positive Airway Pressure Treatment on Glycemic Control and Vascular Function in Patients With Obstructive Sleep Apnea and Type II Diabetes Mellitus.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that obstructive sleep apnea (OSA) contributes to impaired
      glucose homeostasis and associated vasculopathy, and nCPAP treatment of OSA should improve
      glycemic control and vascular function in OSA patients with type II diabetes mellitus. This
      study aims to investigate the therapeutic effects of nCPAP on glycemic control and vascular
      function in patients with OSA and type II diabetes mellitus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive sleep apnoea (OSA) has been reported to be common (17%) in patients with diabetes
      mellitus (DM). Both OSA and DM are highly associated with cardiovascular morbidity and
      mortality. There is growing evidence that OSA may trigger or worsen pre-existing adverse
      metabolic profile indicative of cardiovascular risk. Treatment of OSA with nasal Continuous
      Positive Airway Pressure (nCPAP) has been shown to reduce blood pressure and hence to reduce
      the risk of atherogenesis. In patients with DM, the therapeutic effect of nCPAP is still not
      known, it would be important to delineate any independent effect of OSA on DM and the
      therapeutic effect of nCPAP on glycemic control to reduce the long term risk of macrovascular
      and microvascular complications.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1C</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fasting glucose &amp; fructosamine microalbuminuria blood pressure lipids endothelial function</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>nasal Continuous Positive Airway Pressure treatment for 3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>controls have no treatment, being observed for 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nasal Continuous Positive Airway Pressure</intervention_name>
    <description>A standard treatment for OSA. A portable machine delivers positive pressure through a mask to the upper airway during sleep at night.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>nCPAP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with type II DM on a stable medication regimen (on diet / oral hypoglycaemic
             agents / insulin injections)

          2. Age 25 - 70 years

          3. HbA1C &gt; 7%

          4. AHI &gt;= 15

          5. Able to give written informed consent

        Exclusion Criteria:

          1. Patients with severe co-existing illness or poor functional performance

          2. Patients with peripheral vascular diseases, vasculitis / Raynaud's syndrome or
             thrombocytopenia

          3. Sleep disorders other than OSA

          4. Patients who refuse nCPAP treatment for OSA

          5. Excessive sleepiness causing potential harm (e.g. driver)

          6. HbA1C &gt;=7%

          7. Habitual drinker (defined as more than 3 times a week)

          8. Pregnant or lactating women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary S Ip, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Hong Kong</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Queen Mary Hospital, University Department of Medicine</name>
      <address>
        <city>Pokfulam</city>
        <zip>0000</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <results_reference>
    <citation>West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax. 2007 Nov;62(11):969-74. Epub 2007 Jun 8.</citation>
    <PMID>17557769</PMID>
  </results_reference>
  <verification_date>October 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2009</study_first_submitted>
  <study_first_submitted_qc>April 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2009</study_first_posted>
  <last_update_submitted>October 15, 2013</last_update_submitted>
  <last_update_submitted_qc>October 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Lam Jamie Chung Mei</investigator_full_name>
    <investigator_title>Honorary clinical assistant professor</investigator_title>
  </responsible_party>
  <keyword>Obstructive sleep apnea</keyword>
  <keyword>Type II diabetes mellitus</keyword>
  <keyword>Randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

